Blend Labs Exceeds Q1 Guidance, Reports Breakeven Non-GAAP EPS, and Repurchases $18.6M in Shares
BLND sits 23% above its 52-week low of $1.33.
Summary
Blend Labs, Inc. reported Q1 2026 financial results that exceeded guidance, achieving breakeven non-GAAP EPS and repurchasing $18.6 million in shares, indicating strong operational performance and shareholder value creation.
Key Events · Earnings and Guidance · BLND
-
Exceeded Q1 Guidance
Total revenue of $30.8 million and non-GAAP operating income of $4.1 million both came in above the high end of the company's guidance for the first quarter of 2026.
-
Improved Profitability
Non-GAAP diluted net loss from continuing operations attributable to common stockholders per share was breakeven ($0.00), an improvement from a $0.01 loss in Q1 2025. GAAP operating loss also improved to $5.1 million from $8.0 million year-over-year.
-
Significant Share Repurchase
The company repurchased 11.2 million shares for $18.6 million during the first quarter, with $31.4 million remaining on the existing $50 million authorization. This follows the program authorized on March 10, 2026.
-
Strong Q2 2026 Guidance
Blend Labs provided guidance for Q2 2026, projecting total revenue between $32.0 million and $34.0 million, and non-GAAP operating income between $5.5 million and $6.5 million.
Analysis · BLND · Technology
Blend Labs, Inc. delivered a strong first quarter, surpassing its own guidance for both revenue and non-GAAP operating income. The company achieved breakeven non-GAAP diluted net loss per share, signaling significant operational improvements and a positive trajectory towards profitability. Furthermore, the execution of its share repurchase program, with $18.6 million in shares bought back, demonstrates management's confidence in the company's valuation and commitment to returning capital to shareholders. This performance, coupled with a growing customer base and optimistic Q2 guidance, suggests continued momentum and could positively impact investor sentiment.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BLND was trading at $1.63 on NYSE in the Technology sector, with a market capitalization of approximately $421.7M. The 52-week trading range was $1.33 to $4.49. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.